The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Idecabtagene vicleucel (ide-cel; bb2121), a BCMA-targeted CAR T-cell therapy, in patients with relapsed and refractory multiple myeloma (RRMM): Initial KarMMa results.
 
Nikhil C. Munshi
Stock and Other Ownership Interests - OncoPep
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Amgen; BeiGene; Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Karyopharm Therapeutics; OncoPep; Takeda
Patents, Royalties, Other Intellectual Property - Oncopep
 
Larry D. Anderson, Jr
Honoraria - Amgen; celgene; GlaxoSmithKline; janssen; takeda
Consulting or Advisory Role - amgen; Bristol-Myers Squibb; celgene; GlaxoSmithKline; janssen
Speakers' Bureau - amgen; celgene; Takeda
Research Funding - amgen; Bristol-Myers Squibb; celgene; janssen
 
Nina Shah
Stock and Other Ownership Interests - Indapta Therapeutics
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Genentech/Abbvie; Indapta Therapeutics; Karyopharm Therapeutics; Nektar; Nkarta; Oncopeptides; Precision Biosciences; Sanofi; Seagen; Surface Oncology; TeneoBio
Research Funding - Bluebird Bio; Celgene; Janssen; Sutter Medical Group
 
Sundar Jagannath
Honoraria - Celgene; Karyopharm Therapeutics
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Novartis
Research Funding - Bristol-Myers Squibb (Inst); celgene (Inst); Karyopharm Therapeutics (Inst)
 
Jesus G. Berdeja
Consulting or Advisory Role - Amgen (Inst); BioClinica (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); crispr therapeutics (Inst); Janssen (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Kite, a Gilead company (Inst); Legend Biotech (Inst); prothena (Inst); SERVIER (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Acetylon Pharmaceuticals (Inst); Amgen (Inst); Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Constellation Pharmaceuticals (Inst); CURIS (Inst); Genentech/Roche (Inst); Glenmark (Inst); Janssen (Inst); Kesios Therapuetics (Inst); Lilly (Inst); Novartis (Inst); poseida therapeutics (Inst); Sanofi (Inst); Takeda (Inst); Teva (Inst); Vivolux (Inst)
 
Sagar Lonial
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Juno Therapeutics; Merck; Novartis; Takeda
Research Funding - Bristol-Myers Squibb; Celgene; Takeda
 
Noopur S. Raje
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen Oncology; Merck; Novartis; Takeda
Research Funding - AstraZeneca (Inst)
 
David Samuel DiCapua Siegel
Stock and Other Ownership Interests - Celularity
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen Oncology; Karyopharm Therapeutics; Merck; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen Oncology; Takeda
Research Funding - Celgene (Inst)
 
Yi Lin
Consulting or Advisory Role - Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Gamida Cell (Inst); Juno Therapeutics (Inst); Juno Therapeutics (Inst); Kite/Gilead (Inst); Legend Biotech (Inst); Novartis (Inst); Sorrento Therapeutics (Inst); Vineti (Inst)
Research Funding - Bluebird Bio (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Merck (Inst); Takeda (Inst)
 
Albert Oriol
Consulting or Advisory Role - Amgen; Celgene; Janssen
Speakers' Bureau - Amgen; Celgene
 
Philippe Moreau
Honoraria - Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Novartis; Takeda
Consulting or Advisory Role - Amgen; Celgene; GlaxoSmithKline; Janssen; Takeda
 
Ibrahim Yakoub-Agha
Honoraria - Biotest; Celgene; Gilead Sciences; Janssen; Jazz Pharmaceuticals; Novartis
Travel, Accommodations, Expenses - Gilead Sciences
 
Michel Delforge
Consulting or Advisory Role - Amgen; Celgene; Janssen; Takeda
Speakers' Bureau - Janssen
Research Funding - Celgene; Janssen
 
Fabio Petrocca
Employment - Bluebird Bio
Stock and Other Ownership Interests - Bluebird Bio
Research Funding - Bluebird Bio
 
Jamie Connarn
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Payal Patel
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Liping Huang
Employment - Bayer; Bristol-Myers Squibb
Stock and Other Ownership Interests - Bayer; Bristol-Myers Squibb
 
Timothy Brandon Campbell
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Kristen Hege
Employment - Bristol-Myers Squibb
Leadership - Arcus Biosciences; Mersana
Stock and Other Ownership Interests - Bristol-Myers Squibb
Consulting or Advisory Role - Arcus Biosciences
Research Funding - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb
Other Relationship - Society for Immunotherapy of Cancer
 
Jesus San Miguel
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst); Takeda (Inst)